Jove
Visualize
Contact Us

Related Concept Videos

Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and HIV Surveillance Data to Determine Care Status for People With HIV in Washington, DC.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Exploring Intersectionality Among Latinos Living with HIV: A CHAID Analysis of Health Outcomes and Care Engagement.

Journal of racial and ethnic health disparities·2026
Same author

Characterizing STI testing and diagnosis disparities between Asian people with HIV and other racial/ethnic subpopulations in Washington, District of Columbia: a longitudinal analysis of the DC Cohort, 2018-2023.

Sexual health·2025
Same author

Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC.

Journal of the American Academy of Dermatology·2025
Same author

Integration of Patient Reported Outcomes Data among People with HIV in Washington, DC: A sub-cohort of the DC Cohort Longitudinal Study.

Journal of public health (Berlin, Germany)·2025
Same author

Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC.

AIDS care·2024
Same journal

Aging and HIV: a conversation with Dr. Glenn Treisman. Interview by Jennifer Heflin.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

HIV/HCV coinfection: a new era of treatment.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Making sense of side effects.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Rilpivirine and complera: new first-line treatment options.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Becoming a positive parent: reproductive options for people with HIV.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Giving advocates a voice: an update on the U.S. Positive Women's Network. Interview by Jennifer Heflin.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 7, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
05:06

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Understanding and managing peripheral neuropathy.

Anne Monroe

    BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
    |November 2, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Peripheral neuropathy remains a common issue for individuals with HIV, causing pain and impacting treatment. Despite advances in antiretroviral therapy, nerve complication rates persist, highlighting an ongoing challenge in HIV care.

    More Related Videos

    Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
    03:53

    Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

    Published on: March 15, 2024

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
    05:06

    Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

    Published on: July 14, 2023

    Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
    03:53

    Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

    Published on: March 15, 2024

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Public Health

    Background:

    • Peripheral neuropathy is the most frequent neurological complication in HIV-infected individuals.
    • It significantly contributes to patient discomfort and can impede effective antiretroviral treatment.
    • While other HIV-related neurological issues have declined, peripheral nerve complications remain prevalent.

    Purpose of the Study:

    • To summarize the current understanding of peripheral neuropathy in the context of HIV infection.
    • To highlight the persistent challenge of peripheral nervous system complications despite advances in HIV therapy.

    Main Methods:

    • Literature review and synthesis of existing data on HIV-associated neurological disorders.
    • Analysis of trends in neurological complication incidence following the introduction of HAART.

    Main Results:

    • Peripheral neuropathy is a leading cause of neurological morbidity in people living with HIV.
    • The incidence of central nervous system complications has decreased with highly active antiretroviral therapy (HAART).
    • Rates of peripheral nervous system complications have not shown a similar decrease and remain high.

    Conclusions:

    • Peripheral neuropathy continues to be a significant clinical challenge in HIV management.
    • Further research and therapeutic strategies are needed to address persistent peripheral nerve damage in HIV patients.
    • Effective management of peripheral neuropathy is crucial for improving quality of life and treatment adherence in HIV care.